Literature DB >> 4936538

Trial of maintenance therapy in schizophrenia.

J P Leff, J K Wing.   

Abstract

A double-blind, placebo-controlled trial was carried out to determine the value of maintenance therapy with phenothiazines in a population of outpatients who had recently recovered from an acute episode of schizophrenia. The drug was shown to be significantly more effective than the placebo in preventing relapse. The relationship of the trial patients to the population from which they were selected was defined in terms of clinical, historical, and social data. Maintenance therapy seems of little value in patients with a good prognosis and in the severely ill, but it is of value in the indeterminate group between these two extremes.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4936538      PMCID: PMC1798790          DOI: 10.1136/bmj.3.5775.599

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  16 in total

1.  PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.

Authors:  M S GUTTMACHER
Journal:  Arch Gen Psychiatry       Date:  1964-03

2.  HOME VS HOSPITAL CARE FOR SCHIZOPHRENICS.

Authors:  B PASAMANICK; F R SCARPITTI; M LEFTON; S DINITZ; J J WERNERT; H MCPHEETERS
Journal:  JAMA       Date:  1964-01-18       Impact factor: 56.272

3.  PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION.

Authors:  D M ENGELHARDT; N FREEDMAN; B ROSEN; D MANN; R MARGOLIS
Journal:  Arch Gen Psychiatry       Date:  1964-08

4.  The impact of ataractic drugs on a mental hospital outpatient clinic.

Authors:  M GROSS
Journal:  Am J Psychiatry       Date:  1960-11       Impact factor: 18.112

5.  Termination of chlorpromazine with schizophrenic patients.

Authors:  W W GOOD; M STERLING; W H HOLTZMAN
Journal:  Am J Psychiatry       Date:  1958-11       Impact factor: 18.112

6.  Comparison of chlorpromazine and reserpine in maintenance drug therapy.

Authors:  J R SHAWVER; D R GORHAM; L W LESKIN; W W GOOD; D E KABNICK
Journal:  Dis Nerv Syst       Date:  1959-10

7.  The general practitioner and the schizophrenic patient.

Authors:  C M PARKES; G W BROWN; E M MONCK
Journal:  Br Med J       Date:  1962-04-07

8.  Factors affecting chlorpromazine plasma levels in psychiatric patients.

Authors:  S H Curry; J M Davis; D S Janowsky; J H Marshall
Journal:  Arch Gen Psychiatry       Date:  1970-03

9.  Do psyhiatric out-patients take their drugs?

Authors:  D R Willcox; R Gillan; E H Hare
Journal:  Br Med J       Date:  1965-10-02

10.  Correlation of subjective side effects with plasma concentrations of nortriptyline.

Authors:  M Asberg; B Cronholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1970-10-03
View more
  40 in total

1.  The use of psychotropic drugs in developing countries.

Authors:  T W Harding; T L Chrusciel
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Assessment of drugs in schizophrenia.

Authors:  J P Leff
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

3.  Plasma level studies in psychotropic evaluation.

Authors:  S H Curry
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

4.  Assessment of drugs in schizophrenia. Basic trial design.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

5.  The clinical actions of major tranquillizers.

Authors:  M H Lader
Journal:  Proc R Soc Med       Date:  1977

6.  Long-term follow-up studies of drugs in schizophrenia.

Authors:  N W Imlah
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

7.  Assessment of drugs in schizophrenia. Assessment of psychiatric and social state. 20V.

Authors:  J Leff
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

8.  Prophylactic effect of neuroleptics in symptom-free schizophrenics.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Drug treatment of resistant schizophrenia. Limitations and recommendations.

Authors:  A E Farmer; A Blewett
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

10.  Assessment of drugs in schizophrenia. Diagnosis and patient selection.

Authors:  A D Forrest
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.